Name
Ensuring Appropriate Representation in Clinical Trials to Advance Medicine and Reduce Health Disparities
Date & Time
Tuesday, October 18, 2022, 8:15 AM - 9:30 AM
Location Name
Celebrity 5-8
Description
Experts on research participant engagement will discuss how to design proactive and practical plans for ensuring that clinical trials enroll populations that better advance excellence in clinical research, including discussion of the FDA’s recent draft guidance on clinical trial diversity plans, and the work being done to promote health equity and reduce health disparities through the clinical research enterprise within the FDA’s Office of Minority Health.
Speakers
Quincy Byrdsong - Vice Provost for Health Affairs - Lipscomb University
Richardae Araojo - Associate Commissioner for Minority Health - U.S. Food and Drug Administration
Katherine Cornish - Associate Director of Patient Advocacy and Clinical Research Diversity - WCG Clinical
Rueben C. Warren - Executive Director, National Center for Bioethics for Research and Healthcare - Tuskegee University
Kendal Whitlock - Head of Digital Optimization - Walgreens Health
Richardae Araojo - Associate Commissioner for Minority Health - U.S. Food and Drug Administration
Katherine Cornish - Associate Director of Patient Advocacy and Clinical Research Diversity - WCG Clinical
Rueben C. Warren - Executive Director, National Center for Bioethics for Research and Healthcare - Tuskegee University
Kendal Whitlock - Head of Digital Optimization - Walgreens Health
Learning Objectives
- Discuss the foundation of ethics and compliance in clinical research
- Revisit the landmark article “Ethics and Clinical Research” by Dr. Henry K. Beecher and the regulations which followed
- Identify historical lessons regarding the intersection of ethics and compliance and how these lessons impact the clinical trial enterprise